Analysis of fibroblast growth factor receptor 3 G697C mutation in oral squamous cell carcinomas

被引:12
作者
Aubertin, Johannes
Tourpin, Sophie
Janot, Francois
Ahomadegbe, Jean-Charles
Radvanyi, Francois
机构
[1] Inst Curie, CNRS, Equipe Oncol Mol, UMR 144, F-75248 Paris 05, France
[2] Inst Gustave Roussy, UPRESS 3535, Villejuif, France
[3] Inst Gustave Roussy, Dept Head & Neck Surg, Villejuif, France
关键词
D O I
10.1002/ijc.22285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2058 / 2059
页数:2
相关论文
共 14 条
[1]  
Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139
[2]   Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas [J].
Cappellen, D ;
De Oliveira, C ;
Ricol, D ;
de Medina, SGD ;
Bourdin, J ;
Sastre-Garau, X ;
Chopin, D ;
Thiery, JP ;
Radvanyi, F .
NATURE GENETICS, 1999, 23 (01) :18-20
[3]   Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 [J].
Chesi, M ;
Nardini, E ;
Brents, LA ;
Schrock, E ;
Ried, T ;
Kuehl, WM ;
Bergsagel, PL .
NATURE GENETICS, 1997, 16 (03) :260-264
[4]   MOLECULAR MECHANISMS OF ANGIOGENESIS - FIBROBLAST GROWTH-FACTOR SIGNAL-TRANSDUCTION [J].
FRIESEL, RE ;
MACIAG, T .
FASEB JOURNAL, 1995, 9 (10) :919-925
[5]   Cancer statistics, 2000 [J].
Greenlee, RT ;
Murray, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 2000, 50 (01) :7-33
[6]   P185HER2 MONOCLONAL-ANTIBODY HAS ANTIPROLIFERATIVE EFFECTS INVITRO AND SENSITIZES HUMAN-BREAST TUMOR-CELLS TO TUMOR NECROSIS FACTOR [J].
HUDZIAK, RM ;
LEWIS, GD ;
WINGET, M ;
FENDLY, BM ;
SHEPARD, HM ;
ULLRICH, A .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (03) :1165-1172
[7]  
JOHNSON DE, 1993, ADV CANCER RES, V60, P1
[8]   No evidence of somatic FGFR3 mutation in various types of carcinoma [J].
Karoui, M ;
Hofmann-Radvanyi, H ;
Zimmermann, U ;
Couvelard, A ;
Degott, C ;
Faridoni-Laurens, L ;
Ahomadegbe, JC ;
Gazzeri, S ;
Brambilla, E ;
Clerici, T ;
Charbonnier, P ;
Tresallet, C ;
Mitry, E ;
Penna, C ;
Rougier, P ;
Boileau, C ;
Thiery, JP ;
Nordlinger, B ;
Franc, B ;
Radvanyi, F .
ONCOGENE, 2001, 20 (36) :5059-5061
[9]   ST1571: A paradigm of new agents for cancer therapeutics [J].
Mauro, MJ ;
O'Dwyer, M ;
Heinrich, MC ;
Druker, BJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :325-334
[10]   Clinical and biological characteristics of cervical neoplasias with FGFR3 mutation [J].
Rosty, Christophe ;
Aubriot, Marie-Helene ;
Cappellen, David ;
Bourdin, Jerome ;
Cartier, Isabelle ;
Thiery, Jean Paul ;
Sastre-Garau, Xavier ;
Radvanyi, Francois .
MOLECULAR CANCER, 2005, 4 (1)